A fresh look at coronary microembolization

P Kleinbongard, G Heusch - Nature Reviews Cardiology, 2022 - nature.com
Mechanical stress from haemodynamic perturbations or interventional manipulation of
epicardial coronary atherosclerotic plaques with inflammatory destabilization can release …

Coronary microvascular obstruction: the new frontier in cardioprotection

G Heusch - Basic Research in Cardiology, 2019 - Springer
Cardioprotection aims at infarct size reduction and improvement of clinical outcome from
myocardial infarction. The translation of cardioprotection from preclinical and promising …

Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve …

G Niccoli, RA Montone, B Ibanez, H Thiele… - Circulation …, 2019 - Am Heart Assoc
Primary percutaneous coronary intervention is nowadays the preferred reperfusion strategy
for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring …

Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction

LSF Konijnenberg, P Damman… - Cardiovascular …, 2020 - academic.oup.com
Early mechanical reperfusion of the epicardial coronary artery by primary percutaneous
coronary intervention (PCI) is the guideline-recommended treatment for ST-elevation …

“No-reflow” phenomenon: A contemporary review

G Annibali, I Scrocca, TC Aranzulla, E Meliga… - Journal of clinical …, 2022 - mdpi.com
Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …

[HTML][HTML] Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species

XJ Zhang, X Liu, M Hu, GJ Zhao, D Sun, X Cheng… - Cell metabolism, 2021 - cell.com
Myocardial ischemia-reperfusion (MIR) injury is a major cause of adverse outcomes of
revascularization after myocardial infarction. To identify the fundamental regulator of …

Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction

KF Docherty, RT Campbell, KJM Brooksbank… - Circulation, 2021 - Am Heart Assoc
Background: Patients with left ventricular (LV) systolic dysfunction after myocardial infarction
are at a high risk of developing heart failure. The addition of neprilysin inhibition to renin …

Cardiac MRI to visualize myocardial damage after ST-segment elevation myocardial infarction: a review of its histologic validation

CWH Beijnink, NW van der Hoeven, LSF Konijnenberg… - Radiology, 2021 - pubs.rsna.org
Cardiac MRI is a noninvasive diagnostic tool using nonionizing radiation that is widely used
in patients with ST-segment elevation myocardial infarction (STEMI). Cardiac MRI depicts …

Pathophysiology, diagnosis, and management of the no-reflow phenomenon

J Allencherril, H Jneid, D Atar, M Alam, G Levine… - … Drugs and Therapy, 2019 - Springer
Successful reperfusion of an infarct-related coronary artery by primary percutaneous
intervention or fibrinolysis during acute ST-elevation myocardial infarction (STEMI) does not …

Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction

M Galli, G Niccoli, G De Maria, S Brugaletta… - Nature Reviews …, 2024 - nature.com
Despite prompt epicardial recanalization in patients presenting with ST-segment elevation
myocardial infarction (STEMI), coronary microvascular obstruction and dysfunction (CMVO) …